
TSE:L
This summary was created by AI, based on 10 opinions in the last 12 months.
Loblaw Companies Ltd is recognized as a dominant player in the Canadian grocery and pharmacy sector, benefiting from strong brand loyalty and private label offerings. Despite its robust performance, experts express concerns regarding its valuation, with some calling for caution due to the perception of shrinking growth potential and increased competition from retailers like Walmart and Costco. While some analysts view Loblaw as a defensive investment that could provide stability in uncertain economic times, others critique its recent price surges and suggest trimming positions. The company's acquisition of Shoppers Drug Mart is praised for unlocking profitability, though comparisons with ATD highlight some hesitancy among investors. Overall, while Loblaw has shown resilience amid food inflation, market sentiment varies, indicating mixed outlooks on its future performance.
People have been concerned about this because of food inflation issues. Shoppers Drug Mart has been executing very well for them. He is modelling 12% EPS and 3% dividend growth over the next couple of years. The food inflation rise is over, but they are focusing on more volume, cost cutting and negotiating with vendors. Trading at a good valuation relative to their 5 year. He is buying at these levels.
(A Top Pick Sept 9/15. Down 0.08%.) It was doing quite well, and then pulled back in the last month. Their financial results have been very encouraging. Strong same store sales. She continues to like the grocery space in terms that competition within square footage growth has lessened than it was a few years back. Also, likes Shoppers, the acquisition they did a few years back. They are starting to buy back shares.
She likes the grocery business because the square footage growth has been moderating, and this company has different multiple formats. They have implemented a new SAP IT systems and are starting to see the benefits of that. She also likes Shoppers, their drug retail business. Dividend yield of 1.47%.
(A Top Pick June 9/15. Up 11.8%.) Had originally bought this because of the Shoppers acquisition. She likes both industries. In terms of grocery retail, there has been moderating square footage growth. They are now starting to buy back stock and increasing the dividend. Shoppers has about a 30% share in drug retail. They have good locations and it bodes well with the demographics of the aging consumer.
One of the bigger supermarket chains in the country, and since they bought Shoppers Drug Mart they have gotten even bigger. Have done a good job over the last couple of years to straighten out their information systems, lower costs and getting more competitive. However, at this point, the whole grocers’ space is somewhat challenged because of high food inflation, the Cdn$, and renewed competition. Feels growth from this point on is going to be slow, but he would continue to own it.
(Top Pick Nov 25/16, Down 4.82%) Food deflation is the headwind. They are different than traditional food grocers because they have Shoppers Drug Mart. They now have about a 30% share in food retail as well as in drug retail. They still have a lot of room to improve their margins. This is an attractive entry point to buy this one.